Compare Autodesk Inc (ADSK) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Autodesk Inc vs Quest Diagnostics Inc — how do they compare? Autodesk Inc trades at $206.41 (market cap $44.84B), while Quest Diagnostics Inc trades at $208.21 (market cap $23.51B). The key difference: Autodesk Inc is the larger of the two by market cap, and Quest Diagnostics Inc pays a 1.62% dividend while Autodesk Inc pays none. Which is the better fit depends on your goals.
| ADSK | DGX | |
|---|---|---|
Market Cap | $44.84B | $23.51B |
Sector | Technology | Health |
52-Week High | $326.79 | $216.02 |
52-Week Low | $187.72 | $166.42 |
Enterprise Value | $44.64B | $29.52B |
Dividend Yield | — | 1.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Autodesk Inc
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
